318 related articles for article (PubMed ID: 18317449)
1. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
Yang X; Ferguson AT; Nass SJ; Phillips DL; Butash KA; Wang SM; Herman JG; Davidson NE
Cancer Res; 2000 Dec; 60(24):6890-4. PubMed ID: 11156387
[TBL] [Abstract][Full Text] [Related]
5. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer.
Leu YW; Yan PS; Fan M; Jin VX; Liu JC; Curran EM; Welshons WV; Wei SH; Davuluri RV; Plass C; Nephew KP; Huang TH
Cancer Res; 2004 Nov; 64(22):8184-92. PubMed ID: 15548683
[TBL] [Abstract][Full Text] [Related]
6. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
7. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
Zhang W; Wang L; Fan Q; Wu X; Wang F; Wang R; Ma Z; Yang J; Lu SH
Oncol Rep; 2011 Sep; 26(3):621-8. PubMed ID: 21687957
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
10. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
Woodfield GW; Horan AD; Chen Y; Weigel RJ
Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
[TBL] [Abstract][Full Text] [Related]
11. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
[TBL] [Abstract][Full Text] [Related]
13. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
14. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
17. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
18. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer.
Auer D; Reimer D; Porto V; Fleischer M; Roessler J; Wiedemair A; Marth C; Müller-Holzner E; Daxenbichler G; Zeimet AG
Breast Cancer Res Treat; 2009 Jul; 116(1):103-11. PubMed ID: 18618240
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
Travaglini L; Vian L; Billi M; Grignani F; Nervi C
Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
